LDL/HDL ratio

The LDL/HDL ratio predicts heart disease risk more accurately than either value alone, as it captures the dynamic balance between cholesterol accumulation and clearance. A high ratio indicates excess cholesterol deposition relative to removal capacity, accelerating atherosclerosis even when individual values appear acceptable. The ratio helps identify high-risk patients who might be missed by standard cholesterol screening and guides treatment intensity. It's particularly useful for monitoring treatment response, as improvements in both LDL reduction and HDL elevation are captured in a single improving ratio.

Changes in this ratio from lifestyle modifications or medications directly correlate with cardiovascular event reduction.

Most adults benefit from checking the LDL to HDL ratio yearly as part of a lipid panel. After a meaningful lifestyle or medication change, retest at 6 to 12 weeks.

At baseline / for screening: Once every 12 months from age 30, alongside the rest of your lipid panel. Earlier and more frequent if you have a family history of early cardiovascular disease, elevated Lp(a), or known cardiovascular risk factors.

When monitoring an intervention or change: Retest 6 to 12 weeks after a sustained lifestyle change, such as reducing saturated fat, adding soluble fibre, meaningful weight loss, or a new aerobic routine. The same window applies after starting or adjusting cholesterol-lowering medication (statin, ezetimibe, bempedoic acid, PCSK9 inhibitor).

Note: LDL and HDL respond to lifestyle on different timelines, with LDL within 6 to 12 weeks and HDL over 3 to 6 months. Time retests to capture both inputs at steady state, and wait 4 to 6 weeks after any acute illness before reading the ratio as a stable baseline.